![]() “The Johnson & Johnson vaccine for the most part has been shown to be safe and effective, and I myself was pleased to get it last week.” “I just wanted to note that this recommendation from CDC and FDA was made out of an abundance of caution due to extremely rare blood clots found in six cases out of the 6.8 million people who’ve been vaccinated with Johnson & Johnson,” Scott said in a Tuesday press conference. Phil Scott and administration officials found out about the situation in a call with White House and federal health officials on Tuesday. That symptom has not been reported in Vermont. Johnson & Johnson vaccinations in Vermont are halted for the rest of the week, though state health officials are expecting the pause to be brief.įederal health officials are looking into rare blood clots found in six cases of those who have taken that particular vaccine. ![]() ![]() Most vaccine clinics will not be significantly affected.Īnyone scheduled to receive the Johnson & Johnson vaccine will either receive the Pfizer or Moderna vaccine instead, or the vaccine provider will contact them to reschedule their appointment once FDA and CDC release additional information.Vermont officials have paused administration of the Johnson & Johnson COVID-19 vaccine “out of an abundance of caution,” on a recommendation from the federal government. This week, for example, the state’s Johnson & Johnson allocation is 9,700, compared to nearly 280,000 doses of Pfizer and Moderna the state expects to receive this week. The Johnson & Johnson vaccine makes up only a small portion of Colorado’s weekly vaccine allocation. ![]() The state will share additional information on how this affects Coloradans as soon as it becomes available. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will hold an emergency meeting Wednesday, April 14, to further review the cases and assess their potential significance, and the Food and Drug Administration will continue to investigate. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given,” the FDA and CDC stated in a joint statement. Usually, an anticoagulant drug called heparin is used to treat blood clots. Treatment of this specific type of blood clot is different from the treatment that might typically be administered. All six cases occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination. “In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). Healthcare providers should report any adverse events to the Vaccine Adverse Event Reporting System (VAERS). These symptoms are different from the flu-like symptoms people may experience after receiving a COVID-19 vaccine. ![]() Individuals who received the Johnson & Johnson vaccine more than a month ago are at very low risk of serious side effects.Īnyone who received the Johnson & Johnson vaccine within the last three weeks and who develops severe headache, abdominal pain, leg pain, or shortness of breath should contact their health care provider. These adverse events appear to be extremely rare. FDA PAUSES JOHNSON AND JOHNSON HOW TOThe treatment for these types of blood clots is not the common treatment and thus time is needed to make sure healthcare providers know how to recognize and treat these rare occurrences.ĬOVID-19 vaccine safety and the health and safety of all Coloradans is a top priority. One of the reasons the FDA and CDC are recommending this pause is to ensure health care providers are aware of these potential but rare adverse events and can respond accordingly. The federal government is allowing states to determine whether to pause use, and CDPHE is requiring providers to stop administration of the Johnson & Johnson (Janssen) vaccine until additional information becomes available. who got rare and severe blood clots after receiving the vaccine. In response to the joint CDC and FDA announcement and out of an abundance of caution, the Colorado Department of Public Health and Environment (CDPHE) and the Colorado Joint Vaccine Task Force are alerting providers to temporarily pause use of the Johnson & Johnson (Janssen) COVID-19 vaccine.įederal health officials recommended temporarily suspending use of the vaccine after reviewing reports of six individuals in the U.S. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |